Latest news with #NewMediaWire
Yahoo
25-06-2025
- Health
- Yahoo
Still top cause of death, the types of heart disease people are dying from is changing
Research Highlights: Over the past 50 years, overall heart disease death rates have dropped by 66% and deaths from heart attacks have declined by nearly 90%. The types of heart disease people are dying from most often have shifted from heart attacks to an increase in deaths from heart failure, arrhythmias and hypertensive heart disease. Researchers say this shift, in part, is the result of advances in public health measures focused on prevention and life-saving interventions to improve early diagnosis and treatment, allowing people to live longer while managing chronic heart conditions Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, June 25, 2025 (NewMediaWire) - June 25, 2025 - DALLAS While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a substantial decrease (66%) in overall age-adjusted heart disease death rates, including a nearly 90% drop in heart attack deaths, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association. During that time, there have been major shifts in the types of heart disease people are dying from, with large increases in deaths from heart failure, arrhythmias and hypertensive heart disease. In an analysis of data from the U.S. Centers for Disease Control and Prevention, researchers reviewed the age-adjusted rates of heart disease deaths among adults ages 25 and older from 1970 to 2022. The analysis found: Over this 52-year period, heart disease accounted for nearly one-third of all deaths (31%). During this time, heart disease death rates decreased substantially, from 41% of total deaths in 1970 to 24% of total deaths in 2022. In 1970, more than half of all people who died from heart disease (54%) died because of a heart attack a type of acute ischemic heart disease. The age-adjusted death rate decreased 89% by 2022, when less than one-third of all heart disease deaths (29%) were caused by a heart attack. Conversely, during this time, the age-adjusted death rate from all other types of heart disease (including heart failure, hypertensive heart disease and arrhythmia) increased by 81%, accounting for 9% of all heart disease deaths in 1970 and 47% of all heart disease deaths in 2022. "This distribution shift in the types of heart disease people were dying from the most was very interesting to us," said the study's first author, Sara King, M.D., a second-year internal medicine resident in the department of medicine at Stanford School of Medicine in Stanford, California. "This evolution over the past 50 years reflects incredible successes in the way heart attacks and other types of ischemic heart disease are managed. However, the substantial increase in deaths from other types of heart conditions, including heart failure and arrhythmias, poses emerging challenges the medical community must address." During the decades reviewed: Deaths from arrhythmias had the largest relative increase, with the age-adjusted death rate rising by 450%. However, arrhythmias still accounted for only about 4% of all heart disease deaths in 2022. Arrhythmias occur when electrical impulses to the heart may be too fast, too slow or erratic, causing an irregular heartbeat. Atrial fibrillation is one of the most common types of arrhythmias. The age-adjusted death rate from heart failure a chronic condition where the heart is unable to pump enough blood to meet the body's needs for blood and oxygen increased 146%. The rate of deaths from hypertensive heart disease heart problems that occur because of high blood pressure that is present over a long time increased by 106%. In addition to analyzing the types of heart disease deaths, the researchers also identified several underlying factors that may account for the shift in deaths from ischemic heart disease to other heart conditions. "Over the past 50 years, our understanding of heart disease, what causes it and how we treat it has evolved considerably. That's especially true in how we address acute cardiac events that may appear to come on suddenly," King said. "From the establishment and increased use of bystander CPR and automated external defibrillators to treat cardiac arrest outside the hospital setting, to the creation of systems of care that promote early recognition of and quick procedural and medical intervention to treat heart attacks, there have been great strides made in helping people survive initial acute cardiac events that were once considered a death sentence." Other specific advancements noted in the study included: The invention in the 1960s of coronary artery bypass grafting and the formation of coronary care units improved in-hospital and long-term heart disease death rates. Cardiac imaging improved in the 1970s with coronary angiography, which was capitalized by the advent of balloon angioplasty in 1977, followed by coronary stenting to open blocked heart arteries in the 1980s to 1990s. Simultaneously, there was significant development of medical therapies in the 1970s to 1990s, including thrombolytics and aspirin to reduce blockages; beta blockers to treat high blood pressure; renal-angiotensin-aldosterone system inhibitors to slow the progression of heart and kidney disease; and statins to control cholesterol. These advances all contributed to the decline in deaths from treatment and deaths due to a second or subsequent acute cardiac event. At the turn of the 21st century, high-intensity statin therapy to lower cholesterol and dual antiplatelet therapy to reduce clotting were established, as well as landmark "door-to-balloon" trials that displayed substantial benefits when care to open blocked arteries was expedited. From 2009 to 2022, high-sensitivity troponins that improved the rapid diagnosis of heart attacks and advanced antiplatelet agents to reduce clotting and restore blood flow to the heart further improved death rates, while lipid-lowering therapies such as ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors emerged to improve options for secondary prevention. In addition to medical advances, significant public health strides, such as smoke-free policies, increased emphasis on physical activity and updated practice guidelines that support improved blood pressure and cholesterol management, have driven much of the improvements, according to the report. Study researchers point out that, despite overall reduction in heart disease and the progress in therapies and guidelines, there has been a substantial rise in many CVD risk factors, such as obesity, Type 2 diabetes, hypertension and physical inactivity, in the United States. An aging population is also contributing to an increase in the types of heart disease people are dying from. The report found: From the 1970s to 2022, obesity prevalence has risen from 15% to 40%. Type 2 diabetes including prediabetes, has risen to impact nearly half of all adults in the U.S. in 2020. Hypertension has increased from a prevalence of approximately 30% in 1978 to nearly 50% in 2022. Demographic shifts in the U.S. have also contributed significant changes to the landscape of heart disease mortality. From 1970 to 2022, there has been a notable increase in life expectancy, from 70.9 years to 77.5 years. "All of these risk factors contribute to an ongoing burden of heart disease, especially as related to heart failure, hypertensive heart disease and arrhythmias," said senior author of the paper Latha Palaniappan, M.D., M.S., FAHA, associate dean for research and a professor of medicine at Stanford University School of Medicine. "While heart attack deaths are down by 90% since 1970, heart disease hasn't gone away. Now that people are surviving heart attacks, we are seeing a rise in other forms of heart disease like heart failure. The focus now must be on helping people age with strong, healthy hearts by preventing events, and prevention can start as early as childhood." "The American Heart Association has been a leader in both the medical advancements and the policy and guideline initiatives that have contributed to the reduction in overall heart disease deaths," said Keith Churchwell, M.D., FAHA, the 2024-2025 American Heart Association volunteer president, an associate clinical professor of medicine at Yale School of Medicine in New Haven, Connecticut and an adjunct associate professor of Medicine at the Vanderbilt School of Medicine in Nashville, Tennessee. "Through the nearly $6 billion dollars the Association has invested in scientific research since 1948, we have enhanced the knowledge of how we diagnose and treat heart disease in almost all forms. We have been a catalyst in collaborations with the public and private sectors in support of public health policies to improve the communities in which people live, work, learn and play. And we know, that by following the prescription of our Life's Essential 8(TM) health measures, we can prevent most heart disease and reduce deaths from heart disease by reducing the health risk factors that contribute to it." The American Heart Association's Life's Essential 8 is a measure of cardiovascular health that includes eight essential components for ideal heart and brain health 4 health behaviors and 4 health factors, including: Eat better. Be more active. Quit tobacco. Get healthy sleep. Manage weight. Control cholesterol. Manage blood sugar. Manage blood pressure. "We've won major battles against heart attacks, however, the war against heart disease isn't over. We now need to tackle heart failure and other chronic conditions that affect people as they age," King said. "The cardiology community must prepare to meet this evolving burden through prevention, longitudinal management and multidisciplinary care that supports healthy aging. The next frontier in heart health must focus on preventing heart attacks, and also on helping people age with healthier hearts and avoiding chronic heart conditions later in life." The authors note several limitations to this study: There is likely substantial differences in these reductions in heart disease deaths by age, sex, race, ethnicity, region and urbanization. The study did not analyze data including these components, and research including these factors should be prioritized in future studies to confirm if these overall trends remain valid in subpopulations. The use of multiple iterations of the International Classification of Diseases (ICD) coding system may allow for potential miscoding and presents challenges in maintaining consistency in comparisons across the years. Particularly prominent is the change from ICD-8 to ICD-9 in the year 1979, where the mortality of several conditions (valvular heart disease, hypertensive heart disease, pulmonary heart disease) dramatically increased. The true burden of ischemic heart disease may be underestimated in the findings presented in this study, since certain conditions including heart failure, cardiomyopathy, arrhythmias and in particular ventricular arrhythmias and cardiac arrest, may be overly simplistic. Many of these cases likely have underlying causes that cannot be precisely differentiated using current or past ICD codes. Co-authors, disclosures and funding sources are listed in the manuscript. Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content. Overall financial information is available here. Additional Resources: Multimedia is available on the right column of release link. After June 25, view the manuscript online. AHA news release: Heart disease remains leading cause of death as key health risk factors continue to rise (January 2025) AHA health initiative: Healthy Living Follow AHA/ASA news on X @HeartNews Follow news from the Journal of the American Heart Association @JAHA_AHA ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Cathy Lewis: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
12-06-2025
- Entertainment
- Associated Press
Celebrate Father s Day with a Kick at the Martial Arts History Museum
( NewMediaWire ) - June 11, 2025 - Glendale, CA – Father's Day is always one of the most popular days of the year at the Martial Arts History Museum—and for good reason. It's a time when kids bring their dads to celebrate, laugh, and dive into the thrilling world of martial arts culture. Now, with the museum housed in a much larger and more exciting space, there's even more to explore, experience, and enjoy. This year, we're pulling out all the stops to make it extra special. From samurai armor to ninja legends, from Bruce Lee to Kung Fu Panda, the museum offers a dynamic journey through history, film, and tradition. Whether your dad is a lifelong martial artist or just a fan of great action movies, there's something here to make him smile, reminisce, and maybe even strike a pose. And here's the best part—Dads get in FREE! That's right, it's our way of saying thank you to all the amazing fathers who inspire, protect, and lead with strength, wisdom, and heart. 'Many times kids will blindfold their dad and bring him to the museum. And boy, is he surprised that there is even a museum for the martial arts,' says museum president Michael Matsuda. 'Each and every year, we get more and more people and it's completely packed.' So if you're looking for a Father's Day activity that's unique, meaningful, and full of action, skip the crowded restaurants and surprise Dad with something different. Take him to the Martial Arts History Museum, where he'll be surrounded by iconic legends, powerful traditions, and maybe even a flying sidekick or two. This Father's Day, celebrate the warrior in your life—with honor, fun, and a roundhouse kick of history. The museum opens at 11 am and closes at 6 pm. 201 N. Brand Blvd. B100, Glendale, CA 91203 or visit
Associated Press
11-06-2025
- Health
- Associated Press
Data challenge explores inflammation s hidden role in heart disease
( NewMediaWire ) - June 11, 2025 - DALLAS — Elevated high-sensitivity C-reactive protein (hsCRP) is a marker of inflammation linked to increased risk of heart attacks, strokes and other forms of cardiovascular disease, even in healthy individuals with normal cholesterol. Awareness of elevated hsCRP can help identify people at increased risk and enable appropriate treatment that may improve their health outcomes. To learn more about how hsCRP impacts individuals, the American Heart Association(R), a global force changing the future of health for all, today announced the launch of the Systemic Inflammation Data Challenge, a new research initiative that will leverage advanced data science to explore how inflammation contributes to cardiovascular disease. 'The Systemic Inflammation Data Challenge aims to drive new understanding and inspire better, more equitable care by identifying how systemic inflammation affects cardiovascular outcomes,' said Anum Saeed, M.D., American Heart Association volunteer, member of the expert panel for the data challenge and assistant professor of medicine at the University of Pittsburgh. 'We hope to spark discoveries that inform clinical practice as well as public health strategies through this innovative collaboration of data science researchers and clinicians.' Through the Association's Precision Medicine Platform, scientific researchers participating in the challenge will examine the specific role and mechanisms in which elevated levels of hsCRP contribute to the development of cardiovascular disease. Participants have the option of using multiple datasets provided by the American Heart Association and/or using their own data to investigate how inflammation — especially when influenced by social drivers of health, which are the conditions in which people are born and live — may increase the risk of heart disease. The top three submissions will receive awards totaling $75,000, including a $40,000 first prize. Finalists will present their findings at the American Heart Association's Scientific Sessions, with the goal of publishing results in peer-reviewed journals. Funded in part by Novo Nordisk Inc., the challenge marks a strategic opportunity to identify solutions to, while elevating awareness about, inflammation's overall impact on heart health. For more information or to register for the challenge, visit Additional Resources: ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Michelle Rosenfeld: 214-706-1099; [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
Associated Press
22-05-2025
- Health
- Associated Press
Two decades of progress in heart failure care
( NewMediaWire ) - May 22, 2025 - DALLAS — Hospitalized heart failure patients in the United States are living longer and receiving more optimized evidence-based care, according to new research drawn from nearly two decades of data in the American Heart Association's Get With The Guidelines(R) - Heart Failure registry. Launched in 2005, the Get With The Guidelines - Heart Failure program was created to improve care for people hospitalized with heart failure, a condition that led to the death of about one in three patients within a year. Today, more than 600 hospitals across the country are part of this effort to save lives. The program has helped close persistent care gaps through data-driven benchmarking, hospital toolkits, workshops, webinars and recognition programs, all aimed at accelerating adoption of evidence-based guideline-recommended therapies. 'The Get With The Guidelines program continues to be a cornerstone for improving heart failure care,' said Sabra Lewsey, M.D., MPH, volunteer chair of the American Heart Association's Heart Failure Systems of Care Committee and assistant professor of medicine at Johns Hopkins Medicine. 'Its impact on long-term survival demonstrates how quality improvement efforts can transform patient trajectories.' The research manuscript, published in Circulation: Heart Failure, details how hospitals engaged in the program consistently outperform peers on heart failure process measures and patient outcomes, even after adjusting for variables like hospital size and geographic region. Notably, lower 30-day risk-standardized mortality rates at participating hospitals correlate with significantly better long-term survival for people with heart failure. Insights from the program have helped shape modern understanding of the disease. Among other findings, Get With The Guidelines - Heart Failure data challenged longstanding assumptions that individuals with preserved left ventricular ejection fraction had more favorable prognoses — a discovery that spurred new lines of clinical investigation and public health strategy. Despite measurable progress, challenges remain. 'Heart failure mortality is still too high, and far too few people receive the full benefit of available, evidence-based therapies,' said Gregg Fonarow, M.D., FAHA, longtime American Heart Association volunteer who helped to establish the program. Fonarow is also interim chief of the division of cardiology, director of the Ahmanson-UCLA Cardiomyopathy Center, co-director of the Preventative Cardiology Program and the Eliot Corday Chair in Cardiovascular Medicine and Science at the University of California, Los Angeles. 'This legacy quality improvement program improves the health care landscape for heart failure and serves as a guidepost for other cardiovascular and stroke conditions.' The research authors note that Get With The Guidelines - Heart Failure registry remains a robust engine for future research, now with more than 170 peer-reviewed publications, nearly half of which appear in high-impact journals. 'This program is no longer a data repository but a nexus for outcomes sciences, data science, and implementation science, all of which now drive innovations in personalized care, inform national policy, and strengthen hospital systems across the country,' said Clyde W. Yancy, M.D., FAHA, past volunteer president of the American Heart Association (2009–2010) and chief of cardiology in the department of medicine at Northwestern University's Feinberg School of Medicine, in Chicago. Yancy was also instrumental is championing the development of the Get With The Guidelines program. Additional Resources: ### Statements and conclusions of studies published in the American Heart Association's scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association's overall financial information are available here. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Michelle Rosenfeld: 214-706-1099; [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
Yahoo
21-05-2025
- Health
- Yahoo
PREVENT equation accurately estimated 10-year CVD risk and those with calcium buildup
Research Highlights: The American Heart Association's PREVENTTM risk calculator accurately identified participants who had calcium buildup in their heart arteries and those who had a higher future heart attack risk, in an analysis of about 7,000 adults in New York City referred for heart disease screening. The PREVENT scores also predicted future heart attack risk. Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, May 21, 2025 (NewMediaWire) - May 21, 2025 - DALLAS The PREVENTTM risk calculator helped to identify people with plaque buildup in the arteries of the heart, in addition to predicting their risk of a future heart attack, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association. In addition, when combining PREVENT and a coronary calcium score, risk prediction was further improved, with patients with the highest risk of heart attack matched the group of participants who had a heart attack during the follow-up period. "These findings are important because when we can better predict a patient's risk of heart attack, we can also tailor care and determine who may benefit from treatment to prevent a heart attack, such as cholesterol-lowering medications," said corresponding author Morgan Grams, M.D., Ph.D., the Susan and Morris Mark Professor of Medicine and Population Health at New York University's Grossman School of Medicine in New York City. The PREVENT (Predicting Risk of cardiovascular disease EVENTs) risk calculator, released by the American Heart Association in 2023, can estimate 10-year and 30-year risk for heart attack, stroke, heart failure or all three in adults as young as age 30. PREVENT factors in age, blood pressure, cholesterol, body mass index, Type 2 diabetes status, social determinants of health, smoking and kidney function to estimate future risk of heart attack, stroke or heart failure. One tool for screening heart health is coronary computed tomography angiography (CCTA), a non-invasive imaging test that visualizes plaque buildup in the heart's arteries. From the CCTA, patients are given a coronary artery calcium (CAC) score, which helps to inform decisions about heart disease prevention and treatment, including when it may be appropriate to prescribe cholesterol-lowering medications. In this study, researchers investigated whether the PREVENT score matched the level of calcium buildup according to the CAC score. In addition, they used the PREVENT risk assessment and coronary artery calcium scores, separately and in combination, to predict future heart attack risk and assessed the accuracy of each with the participants who had a heart attack during the follow-up period. They reviewed electronic health records for nearly 7,000 adults who had had CCTA screening at NYU Langone Health in New York City between 2010 and 2024. The analysis found that for all participants: The PREVENT tool-estimated risk of a heart attack was low (less than 5%) for 43.6% of patients; mildly elevated (5%-7.5%) for 15.8% of the participants; moderately increased (7.5%-20%) for 34.4.%; and high (more than 20%) for 6.2% of people in the study. PREVENT scores were directly correlated with CAC scores, meaning those who had high PREVENT scores, indicating a higher risk of heart attack, matched the group who had higher CAC scores. PREVENT risk ranked as low-to-mildly elevated was associated with CAC of less than or equal to 1, which indicates low risk of heart attack. PREVENT risk ranked as moderate-high was associated with participants who had a CAC score higher than 100, which indicates moderate-to-high risk of heart attack. Researchers then added the CAC score to the PREVENT tool to calculate risk of future heart attack, and, together, they more accurately identified the participants who were at higher risk and who had a heart attack during the follow-up period. "The findings illustrate that PREVENT is accurate in identifying people who may have subclinical risk for cardiovascular disease, meaning blocked arteries before symptoms develop," said Grams. "This study used a real-world set of patients, so our findings are important in shaping future guidelines on the use of the PREVENT calculator and coronary computed tomography angiography." Study co-author and American Heart Association volunteer expert Sadiya Khan, M.D., MSc., FAHA, said the CAC score can help classify risk for heart disease by analyzing calcium buildup. "CT scans to evaluate for coronary calcium and extent of coronary artery calcium buildup may be useful when patients are uncertain if they want to start lipid-lowering therapy or if lipid-lowering therapy should be intensified. We have so many tools in our armamentarium for reducing risk of heart attack, we want to be able to optimize treatments for patients, and especially those with higher risk," said Khan, who chaired the writing group for the Association's 2023 Scientific Statement announcing PREVENT, Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health. Study details, background and design: More than 9 million electronic health records at NYU Langone Health in New York City were reviewed and included adults who had coronary computed tomography angiography performed between 2010 and 2024. Participants in this analysis included 6,961 adults between the ages of 30 and 79 years with no history of heart disease. Their average age was 57.5 years; 53% were women, and 77% were noted in the electronic health records as white adults. Participants' CAC scores were compared to the PREVENT scores calculated based on data in the electronic health records including demographics, vital signs, laboratory values and coexisting conditions. Participants who had a heart attack were noted according to the standard ICD-10 diagnosis codes in the electronic health records. Overall, there were 485 heart attacks during the average of 1.2 years of follow-up. Investigators evaluated the accuracy of using PREVENT or CAC score vs. both PREVENT and CAC combined to predict heart attack risk and compared this to data for patients with an ICD-10 code for heart attack. The study had several limitations, including that patients were screened at a single institution and the majority of participants were noted as white, so the findings may not be generalizable to other people. The analysis only included people who had undergone coronary calcium screening, and electronic health records were the sole source of data. In addition, the follow-up time was short at 1.2 years, and the presence of non-calcified plaque in the heart's arteries was not assessed. Finally, the study may overestimate the prevalence of coronary artery calcium in low-risk people since participants in this study were referred for CCTA/CAC score by a health care professional, which means they may have more heart disease risk factors than the general population. Co-authors, disclosures and funding sources are listed in the manuscript. Studies published in the American Heart Association's scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content. Overall financial information is available here. Additional Resources: Multimedia is available on the right column of release link. After May 21, 2025, view the manuscript online. AHA news release: New scientific research will test PREVENT risk calculator among diverse groups (Feb. 2024) AHA news release: Leading cardiologists reveal new heart disease risk calculator (Nov. 2023) Follow AHA/ASA news on X @HeartNews Follow news from the Journal of the American Heart Association @JAHA_AHA ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173 Bridgette McNeill: For Public Inquiries: 1-800-AHA-USA1 (242-8721) and
